ARGOS THERAPEUTICS INC (ARGS) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 141 transactions totaling $14.0M, demonstrating a bullish sentiment with $13.6M in net insider flow. The most recent transaction on Apr 25, 2018 involved a transaction of 27,150 shares valued at $0.
No significant insider buying has been recorded for ARGS in the recent period.
No significant insider selling has been recorded for ARGS in the recent period.
Based on recent SEC filings, insider sentiment for ARGS is bullish with an Insider Alignment Score of 99/100 and a net flow of $13.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ARGOS THERAPEUTICS INC (ARGS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading ARGS stock, having executed 141 transactions in the past 90 days. The most active insider is International S.a. Pharmstandard (Executive), who has made 8 transactions totaling $80.0M.
Get notified when executives and directors at ARGS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 25, 2018 | A. Nicolette Charles | Executive | Disposition | 27,150 | $N/A | $0 | |
| Apr 25, 2018 | R. Harrelson Lori | Executive | Disposition | 22,629 | $N/A | $0 | |
| Apr 25, 2018 | D. Katz Richard | Executive | Disposition | 22,629 | $N/A | $0 | |
| Apr 25, 2018 | D. Abbey Jeffrey | Executive | Disposition | 67,887 | $N/A | $0 | |
| Mar 28, 2018 | D. Katz Richard | Executive | Award | 22,629 | $N/A | $0 | |
| Mar 28, 2018 | D. Abbey Jeffrey | Executive | Award | 67,887 | $N/A | $0 | |
| Mar 28, 2018 | A. Nicolette Charles | Executive | Award | 27,150 | $N/A | $0 | |
| Mar 28, 2018 | R. Harrelson Lori | Executive | Award | 22,629 | $N/A | $0 | |
| Jan 10, 2018 | D. Abbey Jeffrey | Executive | Sale | 124,987 | $0.16 | $20.0K | |
| Jan 10, 2018 | R. Harrelson Lori | Executive | Sale | 64,329 | $0.16 | $10.3K | |
| Jan 10, 2018 | A. Nicolette Charles | Executive | Sale | 100,250 | $0.16 | $16.0K | |
| Jan 10, 2018 | D. Katz Richard | Executive | Sale | 104,435 | $0.16 | $16.7K | |
| Jan 9, 2018 | D. Katz Richard | Executive | Sale | 104,435 | $0.16 | $16.7K | |
| Jan 9, 2018 | D. Abbey Jeffrey | Executive | Sale | 124,987 | $0.16 | $20.0K | |
| Jan 9, 2018 | A. Nicolette Charles | Executive | Sale | 100,250 | $0.16 | $16.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 1 | $79.2M | 85.0% |
Purchase(P) | 56 | $13.8M | 14.8% |
Sale(S) | 13 | $203.2K | 0.2% |
Disposition(D) | 4 | $0 | 0.0% |
Award(A) | 46 | $0 | 0.0% |
Conversion(C) | 21 | $0 | 0.0% |
Insiders at ARGOS THERAPEUTICS INC are accumulating shares at an accelerated pace. With 22 insiders making 141 transactions totaling $13.8M in purchases versus $203.2K in sales, the net buying activity of $13.6M signals strong executive confidence. International S.a. Pharmstandard (Executive) leads the buying activity with $80.0M in transactions across all time.